Inventor · disambiguated record
Christopher James Sloey
Also filed as: SLOEY CHRISTOPHER · SLOEY CHRISTOPHER J · SLOEY CHRISTOPHER JAMES
15 granted patents·7 pending applications·76 citations·filing 2001–2025
90Inventor score
Top patents by PatentIndex Score
22 records- 0194US7790679B2Pharmaceutical formulationsAMGEN INC·Filed 2006·Granted Sep 7, 2010·18 cites·29 claims
- 0293US8383114B2Pharmaceutical formulationsAMGEN INC·Filed 2008·Granted Feb 26, 2013·28 cites·6 claims
- 0392US9320797B2Pharmaceutical formulationsAMGEN INC·Filed 2013·Granted Apr 26, 2016·22 cites·12 claims
- 0484US12318447B2Lyophilized powder configured for reconstitution as a liquid pharmaceutical formulation with reduced viscosity and method of preparing thereofAMGEN INC·Filed 2023·Granted Jun 3, 2025·0 cites·13 claims
- 0583US11464857B2Low-viscosity, high concentration evolocumab formulations and methods of making the sameAMGEN INC·Filed 2018·Granted Oct 11, 2022·4 cites·12 claims
- 0683US8796206B2Aqueous formulation of erythropoiesis stimulating protein stabilised by antioxidants for parenteral administrationSLOEY CHRISTOPHER JAMES·Filed 2008·Granted Aug 5, 2014·3 cites·8 claims
- 0779US12440567B2Aqueous antibody formulation stabilized by antioxidants for parenteral administrationAMGEN INC·Filed 2022·Granted Oct 14, 2025·0 cites·9 claims
- 0877US2025345421A1Reducing viscosity of pharmaceutical formulationsAMGEN INC·Filed 2025·Application pending·0 cites
- 0976US11813328B2Methods for reducing the viscosity of liquid pharmaceutical formulations comprising therapeutic proteinsAMGEN INC·Filed 2015·Granted Nov 14, 2023·1 cites·35 claims
- 1069US2021069334A1Pharmaceutical formulationsAMGEN INC·Filed 2020·Application pending·0 cites
- 1167US11433134B2Aqueous formulation of erythropoiesis stimulating protein stabilised by antioxidants for parenteral administrationSLOEY CHRISTOPHER JAMES·Filed 2014·Granted Sep 6, 2022·0 cites·10 claims
- 1266US2020276313A1Pharmaceutical FormulationsAMGEN INC·Filed 2020·Application pending·0 cites
- 1365US12404344B2Low-viscosity, high concentration evolocumab formulations and methods of making the sameAMGEN INC·Filed 2022·Granted Sep 2, 2025·0 cites·12 claims
- 1465US8980256B2Pharmaceutical formulationsAMGEN INC·Filed 2012·Granted Mar 17, 2015·0 cites·12 claims
- 1560US10668154B2Pharmaceutical formulationsAMGEN INC·Filed 2015·Granted Jun 2, 2020·0 cites·5 claims
- 1655US12103979B2N-acetylated and non-acetylated dipeptides containing arginine to reduce the viscosity of viscous compositions of therapeutic polypeptidesAMGEN INC·Filed 2018·Granted Oct 1, 2024·0 cites·23 claims
- 1755US10653781B2Pharmaceutical formulationsAMGEN INC·Filed 2016·Granted May 19, 2020·0 cites·20 claims
- 1854US2024343795A1Antibody formulationsAMGEN INC·Filed 2022·Application pending·0 cites
- 1952US8314063B2Pharmaceutical formulationsLI TIANSHENG·Filed 2010·Granted Nov 20, 2012·0 cites·24 claims
- 2045US2023078678A1Formulations of human anti-tslp antibodies and methods of treating atopic dermatitisAMGEN INC·Filed 2021·Application pending·0 cites
- 2139US2003104996A1L-methionine as a stabilizer for NESP/EPO in HSA-free formulationsFiled 2001·Application pending·0 cites
- 2236US2013171128A1Reducing viscosity of pharmaceutical formulationsHUANG HOLLY ZHUOHONG·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Christopher James Sloey files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →